Sign in

NCT07887776Completed

Physical Performance and Cognitive Functions in Patients With Chronic Stroke

The Effect of Cognitive Impairment on Upper Extremity Physical Performance and Cognitive Functions in Patients With Chronic Stroke

Source: ClinicalTrials.gov · Last updated 21 Oct 2026

Brief summary (registry, in English)

This study aims to investigate the impact of cognitive impairment on upper extremity physical performance, cognitive skills, and functional independence in individuals with chronic stroke. A total of 66 chronic stroke survivors will be enrolled and categorized into two groups based on their Montreal Cognitive Assessment (MoCA) scores: the Cognitive Impairment Group (n=33) and the Control Group (n=33). Upper extremity performance, cognitive functions, and functional independence will be comprehensively evaluated using standardized clinical outcome measures.

Status (registry)
Completed
Study type
Observational
Enrollment
66 (actual)
First submitted
15 Oct 2026
Start date
1 Jan 2025
Primary completion date
30 Jun 2026
Lead sponsor
Kutahya Health Sciences University
Diseases
Stroke
NCT number
NCT07887776

What you commit to

  • Study type: Observational
  • Participants enrolled: 66
  • From 1 Jan 2025 to the primary completion date, 30 Jun 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Presence of any other concurrent orthopedic or neurological disease affecting physical or cognitive performance

Other illness

  • Having a chronic and severe medical condition (e.g., epilepsy, cerebral palsy)
  • History of recent surgery
  • History of any pre-existing condition affecting cognitive status (e.g., dementia, neurodegenerative diseases)

Other

  • Complete loss of vision or hearing

Who the study is looking for

  • History of ischemic or hemorrhagic stroke diagnosed at least 6 months prior to the study,
  • First-ever stroke
  • Absence of communication or language disorders that would prevent understanding and cooperation
  • Ability to read and write
  • Not currently receiving psychotropic medication treatment
  • Willingness to participate and provision of signed informed consent

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Doç. Dr. Mustafa Kalemli Tavsanli State Hospital
Coordinator of this site? Confirm its status
KütahyaTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.